Rankings
▼
Calendar
VRTX FY 2018 Earnings — Vertex Pharmaceuticals Incorporated Revenue & Financial Results | Market Cap Arena
VRTX
Vertex Pharmaceuticals Incorporated
$125B
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3.0B
+22.5% YoY
Gross Profit
$2.6B
86.6% margin
Operating Income
$635M
20.8% margin
Net Income
$2.1B
68.8% margin
EPS (Diluted)
$8.09
Cash Flow
Operating Cash Flow
$1.3B
Free Cash Flow
$1.2B
Stock-Based Comp.
$325M
Balance Sheet
Total Assets
$6.2B
Total Liabilities
$1.8B
Stockholders' Equity
$4.4B
Cash & Equivalents
$2.7B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3.0B
$2.5B
+22.5%
Gross Profit
$2.6B
$2.2B
+19.2%
Operating Income
$635M
$123M
+415.4%
Net Income
$2.1B
$263M
+695.8%
← Q4 2017
All Quarters
Q1 2018 →